Cargando…
Primary ovarian angiosarcoma: a rare and recognizable ovarian tumor
The diagnosis of primary angiosarcoma of ovary is still a challenge as it has no specific clinical symptoms and is easily confused with other malignant neoplasms in morphology. Here, we described a case of primary ovarian angiosarcoma and reviewed the literature. A 47-year-old female showed a left o...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844967/ https://www.ncbi.nlm.nih.gov/pubmed/33509230 http://dx.doi.org/10.1186/s13048-021-00771-7 |
_version_ | 1783644462404075520 |
---|---|
author | Ye, Hong Lin, Min Li, Ruotong Qin, Shuming Hou, Gang Chen, Hongzhi Li, Xiaomei |
author_facet | Ye, Hong Lin, Min Li, Ruotong Qin, Shuming Hou, Gang Chen, Hongzhi Li, Xiaomei |
author_sort | Ye, Hong |
collection | PubMed |
description | The diagnosis of primary angiosarcoma of ovary is still a challenge as it has no specific clinical symptoms and is easily confused with other malignant neoplasms in morphology. Here, we described a case of primary ovarian angiosarcoma and reviewed the literature. A 47-year-old female showed a left ovary mass. Grossly, the cut surface of the tumor was solid and gray-white with intermediate texture. Some areas were spongy and atropurpureus with a soft texture. Microscopically, the tumor cells were arranged into a variety of different structures with visible hemorrhage. Immunochemically, the tumor cells were positive for CD31, ERG, Fli1, D2–40 and vimentin in a strong and diffused manner. CD34 stain showed focal positivity. Epithelial markers (e.g. CK, CK7, CK8/18 and PAX8) were all negative. Negative immunostaining for SMA, S-100, P53 and calretinin also were detected. The proliferative index (Ki-67) was approximately 40%. After surgery, the patient was treated with radiotherapy, targeted therapy and immunotherapy. In the 9-month follow-up, the patient was survival without evidence of disease. The diagnosis of ovarian angiosarcoma required the careful observation of morphology and the reasonable application of immunohistochemistry. Targeted therapy and immunotherapy are the potential directions for the treatment of angiosarcoma. |
format | Online Article Text |
id | pubmed-7844967 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-78449672021-02-01 Primary ovarian angiosarcoma: a rare and recognizable ovarian tumor Ye, Hong Lin, Min Li, Ruotong Qin, Shuming Hou, Gang Chen, Hongzhi Li, Xiaomei J Ovarian Res Case Report The diagnosis of primary angiosarcoma of ovary is still a challenge as it has no specific clinical symptoms and is easily confused with other malignant neoplasms in morphology. Here, we described a case of primary ovarian angiosarcoma and reviewed the literature. A 47-year-old female showed a left ovary mass. Grossly, the cut surface of the tumor was solid and gray-white with intermediate texture. Some areas were spongy and atropurpureus with a soft texture. Microscopically, the tumor cells were arranged into a variety of different structures with visible hemorrhage. Immunochemically, the tumor cells were positive for CD31, ERG, Fli1, D2–40 and vimentin in a strong and diffused manner. CD34 stain showed focal positivity. Epithelial markers (e.g. CK, CK7, CK8/18 and PAX8) were all negative. Negative immunostaining for SMA, S-100, P53 and calretinin also were detected. The proliferative index (Ki-67) was approximately 40%. After surgery, the patient was treated with radiotherapy, targeted therapy and immunotherapy. In the 9-month follow-up, the patient was survival without evidence of disease. The diagnosis of ovarian angiosarcoma required the careful observation of morphology and the reasonable application of immunohistochemistry. Targeted therapy and immunotherapy are the potential directions for the treatment of angiosarcoma. BioMed Central 2021-01-28 /pmc/articles/PMC7844967/ /pubmed/33509230 http://dx.doi.org/10.1186/s13048-021-00771-7 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Ye, Hong Lin, Min Li, Ruotong Qin, Shuming Hou, Gang Chen, Hongzhi Li, Xiaomei Primary ovarian angiosarcoma: a rare and recognizable ovarian tumor |
title | Primary ovarian angiosarcoma: a rare and recognizable ovarian tumor |
title_full | Primary ovarian angiosarcoma: a rare and recognizable ovarian tumor |
title_fullStr | Primary ovarian angiosarcoma: a rare and recognizable ovarian tumor |
title_full_unstemmed | Primary ovarian angiosarcoma: a rare and recognizable ovarian tumor |
title_short | Primary ovarian angiosarcoma: a rare and recognizable ovarian tumor |
title_sort | primary ovarian angiosarcoma: a rare and recognizable ovarian tumor |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844967/ https://www.ncbi.nlm.nih.gov/pubmed/33509230 http://dx.doi.org/10.1186/s13048-021-00771-7 |
work_keys_str_mv | AT yehong primaryovarianangiosarcomaarareandrecognizableovariantumor AT linmin primaryovarianangiosarcomaarareandrecognizableovariantumor AT liruotong primaryovarianangiosarcomaarareandrecognizableovariantumor AT qinshuming primaryovarianangiosarcomaarareandrecognizableovariantumor AT hougang primaryovarianangiosarcomaarareandrecognizableovariantumor AT chenhongzhi primaryovarianangiosarcomaarareandrecognizableovariantumor AT lixiaomei primaryovarianangiosarcomaarareandrecognizableovariantumor |